Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors

被引:0
|
作者
Yi Wang
Gui-Qi Zhu
Chang-Wu Zhou
Na Li
Chun Yang
Meng-Su Zeng
机构
[1] Fudan University,Department of Radiology, Zhongshan Hospital, Shanghai Institute of Medical Imaging
[2] Fudan University,Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital
来源
European Radiology | 2022年 / 32卷
关键词
Liver neoplasms; Magnetic resonance imaging; Risk stratification; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5166 / 5178
页数:12
相关论文
共 50 条
  • [1] Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors
    Wang, Yi
    Zhu, Gui-Qi
    Zhou, Chang-Wu
    Li, Na
    Yang, Chun
    Zeng, Meng-Su
    EUROPEAN RADIOLOGY, 2022, 32 (08) : 5166 - 5178
  • [2] Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters
    Leyao Wang
    Bing Feng
    Dengfeng Li
    Meng Liang
    Shuang Wang
    Sicong Wang
    Xiaohong Ma
    Xinming Zhao
    European Radiology, 2023, 33 : 3592 - 3603
  • [3] Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters
    Wang, Leyao
    Feng, Bing
    Li, Dengfeng
    Liang, Meng
    Wang, Shuang
    Wang, Sicong
    Ma, Xiaohong
    Zhao, Xinming
    EUROPEAN RADIOLOGY, 2023, 33 (05) : 3592 - 3603
  • [4] Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma
    Granata, Vincenza
    Fusco, Roberta
    Setola, Sergio Venanzio
    Sandomenico, Fabio
    Barretta, Maria Luisa
    Belli, Andrea
    Palaia, Raffaele
    Tatangelo, Fabiana
    Grassi, Roberta
    Izzo, Francesco
    Petrillo, Antonella
    RADIOLOGY AND ONCOLOGY, 2020, 54 (02) : 149 - 158
  • [5] Imaging diagnosis of hepatocellular carcinoma: LI-RADS
    Cunha, Guilherme Moura
    Sirlin, Claude B.
    Fowler, Kathryn J.
    CHINESE CLINICAL ONCOLOGY, 2021, 10 (01)
  • [6] Clinicoradiographic predictors of progression of an intermediate hepatic lesion (LI-RADS 3) to hepatocellular carcinoma (LI-RADS 5)
    Hannan, Lindsay M.
    Ojeda, Patricia I.
    Mieloszyk, Rebecca J.
    Harris, William P.
    Park, James O.
    Bhargava, Puneet
    HEPATOMA RESEARCH, 2021, 7 : 7 - 78
  • [7] LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features
    Cerny, Milena
    Bergeron, Catherine
    Billiard, Jean-Sebastien
    Murphy-Lavallee, Jessica
    Olivie, Damien
    Berube, Joshua
    Fan, Boyan
    Castel, Helene
    Turcotte, Simon
    Perreault, Pierre
    Chagnon, Miguel
    Tang, An
    RADIOLOGY, 2018, 288 (01) : 118 - 128
  • [8] Intrahepatic Cholangiocarcinoma Presenting as LI-RADS 5 "HCC"
    Dhanekula, Raja Koteswar
    Mitchell, Donald G.
    Farber, John L.
    Sama, Ashwin
    Civan, Jesse
    HEPATOLOGY, 2016, 64 : 661A - 661A
  • [9] Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
    Cannella, Roberto
    Burgio, Marco Dioguardi
    Beaufrere, Aurelie
    Trapani, Loic
    Paradis, Valerie
    Hobeika, Christian
    Cauchy, Francois
    Bouattour, Mohamed
    Vilgrain, Valerie
    Sartoris, Riccardo
    Ronot, Maxime
    JHEP REPORTS, 2021, 3 (06)
  • [10] CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
    Zhe Huang
    Ping Ping Zhou
    Shan Shan Li
    Kaiyan Li
    Cancer Imaging, 23